You are here: Home > Institute of Excellence (CPD) > CPD Events > SS3L1 Diabetic Eye Disease

SS3L1 Diabetic Eye Disease

Date: 18/06/2019

Venue: ACO, 374 Cardigan St, Carlton, VIC, 3165

Provider: Australian College of Optometry

Contact: Liz Salvatore, [E], [P] 03 9349 7477

Learning Objectives

  • Explain the factors that should be considered when deciding to initiate treatment in a patient who has been recently diagnosed with diabetic retinopathy (DR)
  • Discuss the rationale for the selection of a particular pharmacologic agent when managing a case of proliferative diabetic retinopathy
  • Outline the alternatives for DR patients who do not respond adequately to anti-VEGF drugs
  • Discuss the current research and future development of more potent pharmacologic agents for the management of DR

Max points awarded: 3.00

Session Information

SS2L1 Diabetic Eye Disease
Activity Type
Face to Face with Assessment
Points for attending & Passing Assessment

NameActivity TypeTherapeutic?Manufacturer/
Points for attending &
Passing Assessment
SS2L1 Diabetic Eye DiseaseFace to Face with AssessmentNoNo3.00

Acknowledgement of Country

In the spirit of reconciliation Optometry Australia acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.